# A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia

> **NCT03674008** · PHASE3 · COMPLETED · sponsor: **Sichuan Haisco Pharmaceutical Group Co., Ltd** · enrollment: 280 (actual)

## Conditions studied

- Sedation or Anesthesia

## Interventions

- **DRUG:** HSK3486
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT03674008
- **Lead sponsor:** Sichuan Haisco Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-09
- **Primary completion:** 2019-01-09
- **Final completion:** 2019-03-10
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03674008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03674008, "A Phase III Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03674008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*